Abstract:Background Transgender and gender diverse (TGD) individuals assigned female at birth (AFAB) often desire menstrual suppression due to dysphoria related to menses. Achieving amenorrhea may be more difficult in the setting of heavy menstrual bleeding (HMB) or a bleeding disorder (BD). The aim of this study was to investigate management patterns and rates of amenorrhea in TGD AFAB individuals with diagnoses of HMB and/or a BD. A secondary aim was to examine the influence of testosterone (T) on achieving amenorrhea. Methods A retrospective chart review was performed at a single academic center. IRB exemption was obtained. AFAB patients aged 10-21 who identified as TGD and had a diagnosis of HMB and/or a BD were identified with ICD-10 codes and using an Electronic Medical Record Search Engine (EMERSE). Variables collected are listed in Tables 1 and 2. Data was analyzed using t-tests and chi-squared tests. Results 121 patients met inclusion criteria. 16 (13.9%) patients had a diagnosed BD. 54 (44.6%) patients had a history of anemia, and 63 (52.1%) had iron deficiency. Patients with a known BD achieved amenorrhea at similar rates to patients without (62.5% vs 65.7%, p=0.78), regardless of T use. Patients that identified as male were more likely to achieve amenorrhea than nonbinary patients or any non-male gender identity ((p = 0.003), p = 0.004) (Table 1). 31 (26.7%) patients achieved amenorrhea with the first medication prescribed. 82 (67.8%) used an estrogen-containing medication for menstrual suppression. 76 (62.8%) patients ever achieved amenorrhea with any combination of hormonal medication. Of patients who achieved amenorrhea, 63 (82.9%) achieved amenorrhea on a single agent, and 12 (15.8%) required 2 agents. The most common agent used that resulted in amenorrhea was continuous oral contraceptive pills (COCs), and the most common combination used to achieve amenorrhea was T and norethindrone acetate (NETA). 55 (45.5%) patients were prescribed T for gender affirmation, and 42 (77.8%) patients achieved amenorrhea during the study period while on T. (Table 2) Of the patients who achieved amenorrhea with T, 44.4% required the use of a second agent, most commonly NETA. Individuals who used T at any point achieved significantly higher rates of amenorrhea than those who did not use T (76.3% vs 43.9%, p<.001) . Conclusions BD diagnosis did not influence rates of amenorrhea, regardless of the use of T. TGD adolescents on T with HMB had lower rates of amenorrhea when compared to prior studies looking at all TGD individuals on T. In addition, almost half of the patients on T also required the use of a second agent to achieve amenorrhea.

109. Primary Care Referrals for Heavy Menstrual Bleeding in Adolescents: A Retrospective Chart Review

PRO53 CLOTTING FACTOR UTILIZATION AND BLEEDING RATES AMONG PERSONS WITH HEMOPHILIA A FROM A LONGITUDINAL STUDY

Driving improvement of diagnosis and awareness of heavy menstrual bleeding in women among physicians

Assessment of Iron Status in Adolescents Presenting to the Emergency Department With Heavy Menstrual Bleeding

Factors associated with receiving surgical treatment for menorrhagia in England and Wales: findings from a cohort study of the National Heavy Menstrual Bleeding Audit

108. Prevalence of bleeding disorders in adolescents presenting with heavy menstrual bleeding and anemia

Standardizing the evaluation and management of iron deficiency anemia secondary to heavy menstrual bleeding in the emergency department

Assessment of rare bleeding disorders in adolescents with heavy menstrual bleeding

Treatment Modalities in Adolescents Who Present with Heavy Menstrual Bleeding

80. Management of Heavy Menstrual Bleeding in Transgender and Gender Diverse Adolescents and Young Adults

Adequate menstrual suppression in adolescents with inherited bleeding disorders often requires multiple treatment changes: Retrospective cohort study of a multidisciplinary clinic

Systematic review and meta-analysis of the etiology of heavy menstrual bleeding in 2,770 adolescent females

Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: a systematic literature review

Prospective evaluation of ISTH‐BAT as a predictor of bleeding disorder in adolescents presenting with heavy menstrual bleeding in a multidisciplinary hematology clinic

Patterns of Pediatric and Adolescent Gynecologic Problems in China: A Hospital-Based Retrospective Study of 97,252 Patients

Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause

Heavy menstrual bleeding and dysmenorrhea in adolescents: A systematic review of self‐management strategies, quality of life, and unmet needs

A Review of Clinical Guidelines on the Management of Iron Deficiency and Iron-Deficiency Anemia in Women with Heavy Menstrual Bleeding

Menstrual management in developmentally delayed adolescent females

Girls referred for amenorrhea: analysis of a patient series from a specialist center

52. Examination of Hymenal Variant Diagnoses Pre- and Post-Evaluation by Pediatric and Adolescent Gynecology